Related Experiment Video
Updated: Jun 19, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Helicobacter pylori infection in children: population-based age-specific prevalence and risk factors in a developing
1Department of Medicine and Pediatrics, Aga Khan University, Karachi, Pakistan.
Insights
Helicobacter pylori seroprevalence in children rises with age and is linked to lower socioeconomic status and parental education. Improving sanitation and education can help reduce H. pylori infection rates.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- Helicobacter pylori (H. pylori) infection is a significant global health concern, particularly in children.
- Understanding the prevalence, age of acquisition, and risk factors is crucial for developing effective prevention strategies.
Purpose of the Study:
- To estimate the prevalence of H. pylori seropositivity in children aged 1-15 years.
- To determine the age of acquisition for H. pylori infection.
- To identify risk factors associated with H. pylori seroprevalence in this pediatric population.
Main Methods:
- Serum samples from 1976 children were analyzed for H. pylori antibodies using ELISA.
- Parental questionnaires collected data on household crowding, water sources, sanitation, and socioeconomic status (SES) using the Hollingshead Index.
Main Results:
- H. pylori seropositivity was 53.5% in children aged 11-15 years.
- Seroprevalence increased with higher crowding indices and was associated with middle and lower SES.
- Multivariate analysis identified age (6-15 years), lower-middle SES, and paternal educational status as significant risk factors.
Conclusions:
- H. pylori seropositivity in children is associated with increasing age, lower-middle socioeconomic status, and father's educational attainment.
- Interventions focusing on improving sanitary conditions and enhancing educational status are recommended to reduce H. pylori seroprevalence.
Aim:
We estimated the prevalence, age of acquisition and risk factors for Helicobacter pylori (H. pylori) seroprevalence in children aged 1-15 years.
Methods:
Exposure was assessed using ELISA. Parents responded to a questionnaire regarding number of individuals sharing house, rooms, water source, latrines, housing and assessment of socioeconomic status (SES) by Hollingshead Index.
Results:
Serum of 1976 children was tested. Helicobacter pylori seropositivity in children aged 11-15 years was 53.5% (OR: 2.0, 95% CI: 1.58-2.5). It increased with moderate crowding index (CRI) of 2-4 to 45.9% (OR: 1.23, 95% CI: 0.92-1.63) and to 51.2% with CRI >4 (OR: 1.52, 95% CI: 1.12-2.06). In middle SES, seropositivity was 50.5% (331/655) (OR: 1.7, 95% CI: 1.29-2.35), whereas in lower SES, it was 47.1% (500/1062) (OR: 1.5, 95% CI: 1.1-2.0). Multivariate analysis showed that Helicobacter pylori seroprevalence was high in children aged 6-10 and 11-15 years (OR: 1.5, 95% CI: 1.2-1.9 and OR: 1.9, 95% CI: 1.56-2.47 respectively), in lower-middle SES (OR: 1.6, 95% CI: 1.2-2.1 and OR: 1.5, 95% CI: 1.10-2.0 respectively) and in uneducated fathers (OR: 1.58, 95% CI: 1.27-1.95).
Conclusion:
Helicobacter pylori seropositivity increases with age, in low-middle SES and is related to father's educational status. Reducing H. pylori seroprevalence will require improvement in sanitary conditions and educational status of the population.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
Peptic Ulcer
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.